Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 87

Sort by

Sort Order Select

Journal Articles

Ixazomib Modulates Bone Remodeling and Actives Sonic Hedgehog Pathways

Daniele Tibullo, PhD, Anna Longo, PhD, Alessandra Romano, MD PhD, Alessandro Barbato, Cesarina Giallongo, PhD, Michelino Di Rosa, PhD, Carmelina Daniela Anfuso, Gabriella Lupo, Concetta Conticello, MD, Nunzio Vicario, PhD, Rosario Gulino, PhD, Rosalba Parenti, PhD, Giuseppe A. Palumbo, MD PhD, Giovanni Li Volti, MD PhD, Francesco Di Raimondo, MD

Blood (2019) 134 (Supplement_1): 4345.

https://doi.org/10.1182/blood-2019-129927

Published: 2019

Journal Articles

Development and Characterisation of an in Vitro Model of Multiple Myeloma

Thomas Lewis, BSc, Elisabeth Jane Walsby, PhD, Stephen Man, Christopher Fegan, Chris Pepper, BSc, PhD

Blood (2018) 132 (Supplement 1): 4505.

https://doi.org/10.1182/blood-2018-99-111842

Published: 2018

Journal Articles

Thymic epithelial cells require p53 to support their long-term function in thymopoiesis in mice

Pedro M. Rodrigues, Ana R. Ribeiro, Chiara Perrod, Jonathan J. M. Landry, Leonor Araújo, Isabel Pereira-Castro, Vladimir Benes, Alexandra Moreira, Helena Xavier-Ferreira, Catarina Meireles, Nuno L. Alves

Blood (2017) 130 (4): 478–488.

https://doi.org/10.1182/blood-2016-12-758961

Published: 2017

Includes: Supplemental data

Journal Articles

RANK-RANKL Mediated Bone Destruction in B-Cell Acute Lymphoblastic Leukemia

Sujeetha A. Rajakumar, MSc, Eniko Papp, PhD, Ildiko Grandal, MSc, Daniele Merico, PhD, Careesa C. Liu, MSc, Bedilu Allo, PhD, Lucia Zhang, Marc Grynpas, PhD, Mark D. Minden, MD PhD, Johann K. Hitzler, MD, Cynthia J. Guidos, PhD, Jayne S. Danska, PhD

Blood (2016) 128 (22): 908.

https://doi.org/10.1182/blood.V128.22.908.908

Published: 2016

Journal Articles

Factor IX-Deficient Mice Have Decreased Skeletal Health

Emily A Larson, Jason A Taylor, MD PhD

Blood (2016) 128 (22): 559.

https://doi.org/10.1182/blood.V128.22.559.559

Published: 2016

Journal Articles

EZH2 Inhibitor GSK126 Exhibits Osteo-Anabolic Properties in MM Bone Disease and Synergizes with Bortezomib to Inhibit MM Cell Viability

Juraj Adamik, PhD, Rebecca Silbermann, MD, Konstantinos Lontos, MD, Peng Zhang, PhD, Quanhong Sun, Deborah Lynn Galson, PhD, G. David Roodman, MD PhD

Blood (2016) 128 (22): 3247.

https://doi.org/10.1182/blood.V128.22.3247.3247

Published: 2016

Journal Articles

Multiple Myeloma and Bone Marrow Microenvironment Immunohistochemical Study of the Expression of 15 Proteins Related to Myeloma Bone Disease

Patrik Flodr, Pavla Latalova, Petra Pusciznova, Tomas Pika, Jaroslav Bacovsky, Vlastimil Scudla, Jiri Minarik

Blood (2015) 126 (23): 5318.

https://doi.org/10.1182/blood.V126.23.5318.5318

Published: 2015

Journal Articles

Clinical, Instrumental, Serological and Histological Findings Suggest That Hemophilia B May be Less Severe Than Hemophilia A

Giancarlo Castaman, MD, Daniela Melchiorre, MD, Silvia Linari, MD

Blood (2015) 126 (23): 4682.

https://doi.org/10.1182/blood.V126.23.4682.4682

Published: 2015

Journal Articles

Pim Inhibition Suppresses Osteoclastogenesis and Tumor Growth in Myeloma

Jumpei Teramachi, DDS, PhD, Masahiro Hiasa, PhD DDS, Asuka Oda, Hirofumi Tenshin, DDS, Ryota Amachi, DDS, PhD, Takeshi Harada, MDPhD, Derek Hanson, Keiichiro Watanabe, DDS, PhD, Shiro Fujii, MD, Kumiko Kagawa, MD, Shingen Nakamura, MD PhD, Hirokazu Miki, MD PhD, Itsuro Endo, MD PhD, Shuji Ozaki, MD PhD, Toshio Matsumoto, MD PhD, Masahiro Abe, MD PhD

Blood (2015) 126 (23): 4203.

https://doi.org/10.1182/blood.V126.23.4203.4203

Published: 2015

Journal Articles

Drug Resistant Myeloma Cells Cause More Severe Bone Destruction in Myeloma

Mu Hao, MD PhD, Zhimin Gu, PhD, Reinaldo Franqui Machin, Hongwei Xu, Gregory S. Thomas, PhD, Lugui Qiu, MD PhD, Guido J Tricot, MD PhD, Fenghuang Zhan, MD PhD

Blood (2015) 126 (23): 839.

https://doi.org/10.1182/blood.V126.23.839.839

Published: 2015

Journal Articles

Assessment of the Parameters of Myeloma Bone Disease Signaling to the Extent of Skeletal Involvement, Bone Mineral Turnover and Activity of Multiple Myeloma

Jiri Minarik, Zuzana Hermanova, Pavla Petrova, Jana Zapletalova, Jan Hrbek, Petra Pusciznova, Jaroslav Bacovsky, Tomas Pika, Miroslav Herman, Vlastimil Scudla

Blood (2015) 126 (23): 1754.

https://doi.org/10.1182/blood.V126.23.1754.1754

Published: 2015

Journal Articles

Fc Receptor Targeting Reduces Bone Disease in a Pre-Clinical Model of Multiple Myeloma

Mark T Williams, BSc Hons, PhD, Katya Thümmler, PhD, Susan Kitson, Bsc Hons, Richard Soutar, MD PhD, Carl S Goodyear, BSc Hons, PhD

Blood (2015) 126 (23): 3011.

https://doi.org/10.1182/blood.V126.23.3011.3011

Published: 2015

Journal Articles

Myeloma Cell-Derived Runx2 Promotes Myeloma Progression and Bone-Homing

Mei Li, PhD, Timothy N Trotter, BS, Deniz Peker, MD, Patrick D Rowan, BS, Pan Qianying, MD, Suva J. Larry, PhD, Amjad Javed, PhD, Yang Yang, MD PhD

Blood (2014) 124 (21): 724.

https://doi.org/10.1182/blood.V124.21.724.724

Published: 2014

Journal Articles

Heparanase Promotes Myeloma Metastasis By Inducing EMT-like Features in Both Myeloma Cells and Endothelial Cells

Qianying Pan, MD, Patrick D Rowan, BS, Racquel Innis-Shelton, MD, Timothy N Trotter, BS, Mei Li, PhD, Deniz Peker, MD, Larry J Suva, PhD, Yang Yang, MD PhD

Blood (2014) 124 (21): 2025.

https://doi.org/10.1182/blood.V124.21.2025.2025

Published: 2014

Journal Articles

Age-Associated Bone Disease in Factor VIII-Deficient Mice

Emily A. Larson, Urszula T. Iwaniec, PhD, Sigrid C. Holmgren, MS, Russell T. Turner, PhD, Michael Recht, MD PhD, Jason A. Taylor, MD PhD

Blood (2014) 124 (21): 2798.

https://doi.org/10.1182/blood.V124.21.2798.2798

Published: 2014

Journal Articles

Robust Assessment of Genomic Imbalance in Diffuse Large B-Cell Lymphoma Confirms Inferior Outcome Is Associated with Genomic Complexity and Identifies Potential Therapeutic Pathway Targets

Lizalynn Dias, PhD, Venkata Thodima, PhD, Asha Guttapalli, M.S., Geetu Mendiratta, PhD, Sergei I Syrbu, MD, Jane Houldsworth, PhD

Blood (2014) 124 (21): 2993.

https://doi.org/10.1182/blood.V124.21.2993.2993

Published: 2014

Journal Articles

Assessment of Signalling Pathways in Myeloma Bone Disease Using Selected Parameters of Bone Marow Microenvironment

Jiri Minarik, MD PhD, Patrik Flodr, MD, Tomas Pika, MD PhD, Jaroslav Bacovsky, MD PhD, Pavla Latalova, MD, Petra Pusciznova, MD, Vlastimil Scudla, prof, MD PhD

Blood (2014) 124 (21): 5679.

https://doi.org/10.1182/blood.V124.21.5679.5679

Published: 2014

Journal Articles

Activation of Non-Canonical Immune Signalling Pathways Drives Marrow Failure in a Murine Model of MDS

Rawa Ibrahim, BSc, Joanna Wegrzyn, PhD, Linda Ya-Ting Chang, PhD BSc, Patricia Umlandt, BSc, Jeff Lam, BSc, Megan Fuller, BSc, Aly Karsan, MD

Blood (2014) 124 (21): 3246.

https://doi.org/10.1182/blood.V124.21.3246.3246

Published: 2014

Journal Articles

Humanized Anti-CD26 Monoclonal Antibody Inhibits Osteoclast Bone Resorption Activity Via Blockade Of P38MAPK Signaling In Multiple Myeloma

Hiroko Nishida, M.D., Ph.D., Hiroko Madokoro, Hiroshi Suzuki, Michiie Sakamoto, M.D., Ph.D., Chikao Morimoto, M.D., Ph.D., Taketo Yamada, M.D., Ph.D

Blood (2013) 122 (21): 1918.

https://doi.org/10.1182/blood.V122.21.1918.1918

Published: 2013

Journal Articles

In Vitro Generation Of Osteoclasts From Interleukin-3 (IL-3)-Dependent Mouse Hematopoietic Cells

Shunqing Wang, MD, Huixian Hong, M.D.

Blood (2013) 122 (21): 4842.

https://doi.org/10.1182/blood.V122.21.4842.4842

Published: 2013

NARROW

Ixazomib Modulates Bone Remodeling and Actives Sonic Hedgehog Pathways

Development and Characterisation of an in Vitro Model of Multiple Myeloma

Thymic epithelial cells require p53 to support their long-term function in thymopoiesis in mice

RANK-RANKL Mediated Bone Destruction in B-Cell Acute Lymphoblastic Leukemia

Factor IX-Deficient Mice Have Decreased Skeletal Health

EZH2 Inhibitor GSK126 Exhibits Osteo-Anabolic Properties in MM Bone Disease and Synergizes with Bortezomib to Inhibit MM Cell Viability

Multiple Myeloma and Bone Marrow Microenvironment Immunohistochemical Study of the Expression of 15 Proteins Related to Myeloma Bone Disease

Clinical, Instrumental, Serological and Histological Findings Suggest That Hemophilia B May be Less Severe Than Hemophilia A

Pim Inhibition Suppresses Osteoclastogenesis and Tumor Growth in Myeloma

Drug Resistant Myeloma Cells Cause More Severe Bone Destruction in Myeloma

Assessment of the Parameters of Myeloma Bone Disease Signaling to the Extent of Skeletal Involvement, Bone Mineral Turnover and Activity of Multiple Myeloma

Fc Receptor Targeting Reduces Bone Disease in a Pre-Clinical Model of Multiple Myeloma

Myeloma Cell-Derived Runx2 Promotes Myeloma Progression and Bone-Homing

Heparanase Promotes Myeloma Metastasis By Inducing EMT-like Features in Both Myeloma Cells and Endothelial Cells

Age-Associated Bone Disease in Factor VIII-Deficient Mice

Robust Assessment of Genomic Imbalance in Diffuse Large B-Cell Lymphoma Confirms Inferior Outcome Is Associated with Genomic Complexity and Identifies Potential Therapeutic Pathway Targets

Assessment of Signalling Pathways in Myeloma Bone Disease Using Selected Parameters of Bone Marow Microenvironment

Activation of Non-Canonical Immune Signalling Pathways Drives Marrow Failure in a Murine Model of MDS

Humanized Anti-CD26 Monoclonal Antibody Inhibits Osteoclast Bone Resorption Activity Via Blockade Of P38MAPK Signaling In Multiple Myeloma

In Vitro Generation Of Osteoclasts From Interleukin-3 (IL-3)-Dependent Mouse Hematopoietic Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only